financetom
Business
financetom
/
Business
/
Tesla Faces Automotive Sales Stress, AI Optimism, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tesla Faces Automotive Sales Stress, AI Optimism, UBS Says
Jul 24, 2024 11:18 AM

01:53 PM EDT, 07/24/2024 (MT Newswires) -- Tesla (TSLA) is grappling with slowing automotive sales and declining profit margins with stock optimism underpinned by bullish artificial intelligence and robotaxi speculation, UBS Securities said Wednesday in a report.

The stock, trading at over 100 times its run-rate EPS of $2.25, reflects inflated expectations for AI projects, UBS said.

"Tesla is being priced on future optionality" for developing self-driving cars and humanoid robots, UBS said, "It's not being priced on auto or even energy."

If confidence in AI initiatives wanes, especially around robotaxi day on Oct. 10, the stock faces more downside risk, UBS said.

UBS reiterated its sell rating for Tesla with a 12-month price target of $197.

On Tuesday, Tesla's Q2 earnings missed market expectations amid lower vehicle prices and restructuring charges. On Wednesday, Chief Executive Officer Elon Musk posted a poll on X on whether the company should invest $5 billion in his artificial intelligence startup xAI, assuming "several credible outside investors" set the valuation.

Tesla shares fell 10% in recent Wednesday trading, heading for the second-biggest decline on the S&P 500.

Price: 220.96, Change: -25.43, Percent Change: -10.32

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
T2 Biosystems, Prxcision to Market Diagnostic Solutions for Bloodstream Infections, Antibiotic Resistance
T2 Biosystems, Prxcision to Market Diagnostic Solutions for Bloodstream Infections, Antibiotic Resistance
Oct 11, 2024
12:36 PM EDT, 10/08/2024 (MT Newswires) -- T2 Biosystems ( TTOO ) and Prxcision said Tuesday they will comarket diagnostic solutions to identify suspected bloodstream infections and sepsis, and tackle the growing issue of antibiotic resistance. T2 Biosystems' ( TTOO ) fast blood tests, combined with Prxcision's AI platform, will provide quick identification of pathogens in hours, not days, and...
Boeing Commercial Aircraft Deliveries Increased in Q3
Boeing Commercial Aircraft Deliveries Increased in Q3
Oct 11, 2024
12:40 PM EDT, 10/08/2024 (MT Newswires) -- Boeing ( BA ) said Tuesday it delivered a total of 116 commercial aircraft in Q3, up from 92 in Q2. Q3 deliveries included including 92 737s, six 767s, four 777s, and 14 787s, the company said. Year-to-date commercial deliveries totaled 291, the company said In the defense, space and security sector, Boeing...
Bank of America names Brabazon co-head of global M&A, memo says
Bank of America names Brabazon co-head of global M&A, memo says
Oct 11, 2024
LONDON, Oct 8 (Reuters) - Bank of America ( BAC ) has named Eamon Brabazon co-head of global mergers and acquisitions, alongside Ivan Farman, according to an internal email seen by Reuters. Brabazon, who has been with the bank around nine years, was most recently head of M&A in Europe, Middle East and Africa. The bank said Brabazon advised on...
Scilex Holding Completes $50 Million Registered Convertible Financing
Scilex Holding Completes $50 Million Registered Convertible Financing
Oct 11, 2024
12:42 PM EDT, 10/08/2024 (MT Newswires) -- Scilex Holding ( SCLX ) said Tuesday it has completed its registered direct offering of $50 million in new tranche B senior secured convertible notes and warrants to buy up to 7.5 million shares. The notes have an original issue discount of 10.0% and have a 5.5% annual interest rate, maturing two years...
Copyright 2023-2026 - www.financetom.com All Rights Reserved